trans-4,5-Epoxy-(E)-oct-2-enal
| Common Name: |
trans-4,5-Epoxy-(E)-oct-2-enal |
| IUPAC Name: |
(E)-3-[(2R,3R)-3-propyloxiran-2-yl]prop-2-enal |
| Molecular Formula: |
C8H12O2 |
| SMILES: |
CCC[C@@H]1[C@H](O1)/C=C/C=O |
| Inchi: |
1S/C8H12O2/c1-2-4-7-8(10-7)5-3-6-9/h3,5-8H,2,4H2,1H3/b5-3+/t7-,8-/m1/s1 |
| Inchi Key: |
RBBPXPMPGIPSJY-LFHXBRCSSA-N |
| Cas No: |
134452-45-2 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
2 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
140.18 |
| Mass (g/mol) |
140.084 |
| Molar Refractivity |
39.27 |
| Net Charge |
|
| HBD |
|
| HBA |
2 |
| Rt Bonds |
4 |
| Rings |
1 |
| TPSA |
29.60 |
| Hetero Atoms |
2 |
| Heavy Atoms |
10 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
239.00 to 240.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.0393 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.62 |
| LogP |
1.309 |
| iLOGP |
1.96 |
| XLOGP3 |
0.96 |
| WLOGP |
1.31 |
| MLOGP |
0.65 |
| ESOL Log S |
-1.05 |
| ESOL Solubility (mg/ml) |
12.5 |
| ESOL Solubility (mol/l) |
0.089 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-1.17 |
| Ali Solubility (mg/ml) |
9.5 |
| Ali Solubility (mol/l) |
0.07 |
| Ali Class |
Very soluble |
| Silicos-IT LogSw |
-0.92 |
| Silicos-IT Solubility (mg/ml) |
16.9 |
| Silicos-IT Solubility (mol/l) |
0.12 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.47 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.751 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.81 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
